Solana (SOLUSD) last traded at 108.62, up 6.47% on the session and marking its second consecutive higher close.
Trend and moving averages
The chart is described as above the 200-day average but with a mixed short-term structure. Price sits 28.14% above its 20-day average (84.76), 37.44% above its 50-day (79.03) and 33.36% above its 200-day (81.45). All three averages sit well below the current price, and the 50-day sits beneath the 200-day.
Momentum and volatility
The 14-day RSI reads 85.8, a level flagged as elevated and often described as overbought. The 14-day ATR is 4.94, or 4.55% of price. That volatility ranks in the 42nd percentile against Solana’s own past year, so day-to-day range is close to the middle of its twelve-month spread rather than at an extreme.
Price sits within its recent swings: the 20-day range runs from a 73.50 low to a 109.86 high, and the 60-day range extends down to 70.23 with the same 109.86 top. The last price at 108.62 is just under that shared swing high.
Range and performance
The range picture places SOLUSD at 25% of its 52-week span. It stands 57.17% below the 52-week high of 253.61 and 80.79% above the 52-week low of 60.08. That high was set 343 sessions ago, while the low is more recent at 82 sessions back. Over rolling windows, Solana is up 15.99% on the week, 47.72% on the month and 32.61% on the quarter, but down 49.34% across the year.
The weekly frame reads below the 50-week average but with a mixed short-term structure. Price is 33.77% above the 20-week average (81.20) yet 3.45% below the 50-week average (112.50). Weekly RSI is 61.0, a milder reading than the daily 85.8, and last week closed up 13.89%. The two timeframes diverge: the daily structure sits above its long-run average with an elevated RSI, while the weekly picture is still below its 50-week line, so the longer horizon has not yet cleared the level the daily chart has.
Over the past year Solana remains down 49.34% despite the recent monthly and quarterly gains.
Descriptive technical summary generated by the ForexBullion Research Team from our own price feed. Not investment advice.




